Cargando…
Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population
Background: Diabetes is an immunocompromising condition, and diabetic children should receive the 23-valent pneumococcal polysaccharide (PPSV23) vaccine as part of their preventive care because of their increased risk for invasive pneumococcal disease. This recommendation is often not followed, howe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Division of Ochsner Clinic Foundation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477126/ https://www.ncbi.nlm.nih.gov/pubmed/36189088 http://dx.doi.org/10.31486/toj.22.0036 |
_version_ | 1784790288662790144 |
---|---|
author | Mirza, Aymen Jagadish, Apoorva Trimble, Kelsey Olanrewaju, Adijat |
author_facet | Mirza, Aymen Jagadish, Apoorva Trimble, Kelsey Olanrewaju, Adijat |
author_sort | Mirza, Aymen |
collection | PubMed |
description | Background: Diabetes is an immunocompromising condition, and diabetic children should receive the 23-valent pneumococcal polysaccharide (PPSV23) vaccine as part of their preventive care because of their increased risk for invasive pneumococcal disease. This recommendation is often not followed, however, and at our institution, we discovered that a factor limiting vaccine administration was lack of knowledge about the recommendation among residents. Methods: Our objective with this quality improvement initiative was to improve pneumococcal vaccination rates among the inpatient pediatric diabetic population to 70% in 6 months. Three education and awareness initiatives were conducted during the postintervention period of March 2021 to August 2021 at St. Mary Medical Center in Shreveport, Louisiana. All pediatric diabetic patients from age 2 to 18 years who were admitted to the inpatient general pediatrics or critical care services were included. The primary outcome was vaccination with PPSV23. Results: We studied 63 pediatric patients with a mean age of 12.7 years. The vaccination ordering rate during the 6 months prior to the implementation of the quality improvement initiatives was 41%. In the 6 months postintervention, the overall vaccination ordering rate improved to 81%. During data collection, however, we discovered that even though the residents were assessing for vaccine eligibility and ordering the vaccines, not all vaccines were administered prior to discharge. In the preintervention period, the overall vaccine administration rate was 27%, improving to 42% in the postintervention period. Conclusion: Simple interventions that included resident education, development of a smart phrase in the electronic medical record, and liaison with pharmacy led to an increase in the pneumococcal vaccination ordering rate for pediatric patients with diabetes. However, we did not anticipate that the vaccination ordering and administration rates would be different when we initiated the project and had therefore focused our interventions on resident education only. Our discovery of the difference between vaccination ordering and vaccination administration helped identify 2 other areas for improvement: nursing education and additional improvement of the electronic medical record. |
format | Online Article Text |
id | pubmed-9477126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Academic Division of Ochsner Clinic Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-94771262022-09-29 Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population Mirza, Aymen Jagadish, Apoorva Trimble, Kelsey Olanrewaju, Adijat Ochsner J Quality Improvement Background: Diabetes is an immunocompromising condition, and diabetic children should receive the 23-valent pneumococcal polysaccharide (PPSV23) vaccine as part of their preventive care because of their increased risk for invasive pneumococcal disease. This recommendation is often not followed, however, and at our institution, we discovered that a factor limiting vaccine administration was lack of knowledge about the recommendation among residents. Methods: Our objective with this quality improvement initiative was to improve pneumococcal vaccination rates among the inpatient pediatric diabetic population to 70% in 6 months. Three education and awareness initiatives were conducted during the postintervention period of March 2021 to August 2021 at St. Mary Medical Center in Shreveport, Louisiana. All pediatric diabetic patients from age 2 to 18 years who were admitted to the inpatient general pediatrics or critical care services were included. The primary outcome was vaccination with PPSV23. Results: We studied 63 pediatric patients with a mean age of 12.7 years. The vaccination ordering rate during the 6 months prior to the implementation of the quality improvement initiatives was 41%. In the 6 months postintervention, the overall vaccination ordering rate improved to 81%. During data collection, however, we discovered that even though the residents were assessing for vaccine eligibility and ordering the vaccines, not all vaccines were administered prior to discharge. In the preintervention period, the overall vaccine administration rate was 27%, improving to 42% in the postintervention period. Conclusion: Simple interventions that included resident education, development of a smart phrase in the electronic medical record, and liaison with pharmacy led to an increase in the pneumococcal vaccination ordering rate for pediatric patients with diabetes. However, we did not anticipate that the vaccination ordering and administration rates would be different when we initiated the project and had therefore focused our interventions on resident education only. Our discovery of the difference between vaccination ordering and vaccination administration helped identify 2 other areas for improvement: nursing education and additional improvement of the electronic medical record. Academic Division of Ochsner Clinic Foundation 2022 2022 /pmc/articles/PMC9477126/ /pubmed/36189088 http://dx.doi.org/10.31486/toj.22.0036 Text en ©2022 by the author(s); Creative Commons Attribution License (CC BY) https://creativecommons.org/licenses/by/4.0/©2022 by the author(s); licensee Ochsner Journal, Ochsner Clinic Foundation, New Orleans, LA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (creativecommons.org/licenses/by/4.0/legalcode) that permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Quality Improvement Mirza, Aymen Jagadish, Apoorva Trimble, Kelsey Olanrewaju, Adijat Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population |
title | Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population |
title_full | Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population |
title_fullStr | Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population |
title_full_unstemmed | Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population |
title_short | Improving Pneumococcal Vaccination Rates in an Inpatient Pediatric Diabetic Population |
title_sort | improving pneumococcal vaccination rates in an inpatient pediatric diabetic population |
topic | Quality Improvement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477126/ https://www.ncbi.nlm.nih.gov/pubmed/36189088 http://dx.doi.org/10.31486/toj.22.0036 |
work_keys_str_mv | AT mirzaaymen improvingpneumococcalvaccinationratesinaninpatientpediatricdiabeticpopulation AT jagadishapoorva improvingpneumococcalvaccinationratesinaninpatientpediatricdiabeticpopulation AT trimblekelsey improvingpneumococcalvaccinationratesinaninpatientpediatricdiabeticpopulation AT olanrewajuadijat improvingpneumococcalvaccinationratesinaninpatientpediatricdiabeticpopulation |